This can help you feel your best
Expect: Nausea Vomiting Constipation or diarrhea Belching Abdominal pain Reduced appetite Other observed effects include: Headache Dyspepsia Abdominal distension Gas, gastritis Gastroesophageal reflux symptoms Diabetic retinopathy progression in some patients with diabetes Hypoglycemia when used with insulin or sulfonylureas Modest increases in amylase and lipase Injection site reactions Report any new severe abdominal pain, vision changes, or persistent GI symptoms to your clinician
(PubMed) Gensler HL, Williams T, Huang AC, Jacobson EL
Tupelo, Mississippi Featured Points of Interest Click any photo to view larger photos
Canadian regulations permit the sale of research peptides when properly labeled and marketed for research purposes only
Semaglutide Market was valued at USD 17.11 Billion in 2025 and is expected to reach USD 44.34 Billion by 2035, growing at a CAGR of 9.99% over 2026-2035